Twitter Beğeni Hilesi

📈 Monitor your blood pressure🩸 with your smartphone! @Biospectal SA's application OptiBP is now available in Switzerland. Place your fingertip on the camera lens, and get a result in 30 seconds. #innovation #health #lifesciences #digitalhealth bioalps.org/monitor-blood-…

Prof. Antoine Geissbuhler is BioAlps President, Director of Education and Research at HUG and was recently appointed Dean of the Faculty of Medicine at Université de Genève. Find out more about his new mission and his vision. bioalps.org/interview-prof…

Une équipe de scientifiques de notre École et de SantAnnaPisa a développé une main bionique révolutionnaire qui permet aux amputé·es de ressentir la température et de distinguer le contact humain du contact artificiel. - via @radiotelesuisse rts.ch/play/tv/19h30/…

#Startupfit success | Lymphatica Medtech awarded FDA Breakthrough Device Designation bit.ly/3uyU1ul via startupticker #Swisstech #VDtech cc Lymphatica Medtech

Postdoc and PhD positions are open in our unifrBiology department. Have a look here. #hiring #researchjobs

Two SIB Resources for #structuralbiology, SWISS-MODEL and #ModelArchive by Torsten Schwede's group Biozentrum, University of Basel, were recently recognized at the European level by ELIXIR Europe. Read the interview with Team Lead Software Development, Gerardo Tauriello: sib.swiss/news/european-…

A l’heure où, en Suisse, une personne sur cinq est susceptible de souffrir d’un cancer avant l’âge de 70 ans, les progrès fulgurants de la science des données et de l’intelligence artificielle dans le domaine de l’oncologie méritent toute notre attention. Olivier Michielin, chef

🎉 We are thrilled to announce we have received Breakthrough Device Designation (BDD) from the US FDA for our investigational ARC-BCI™ System based on clinical data from two human feasibility studies. This makes us the FIRST company in the world to receive breakthrough

☕ 🥐 Hi from our Café+Croissant! Our signature #event took place at @campusbiotech today! 🔍 Can you spot yourself? Thank you to our partners Wyss Center & BioAlps - Life Sciences Cluster 🇨🇭 as well as everyone who attended! #networking #geneva #community #startup

🌐 Explore the world of partnerships at hashtag#Tech4Growth Conference 2024 on 23 September! Join us at the Tech4Growth Partnering and Matchmaking Conference, organised by EPFL Innovation Park and Innosuisse: bioalps.org/tech4growth-co…

Release Therapeutics announced the closure of a CHF 3.3 Million Seed financing round with private investors. The financing follows the Company’s first preclinical results in animal models of metachromatic leukodystrophy (MLD). bioalps.org/release-therap…

🎙️ Thank you, Unite 2 Fight Paralysis, the podcast from United 2 Fight Paralysis (U2FP), for shining a light on the potential for investigational ARC-EX Therapy to address upper limb mobility and strength challenges after spinal cord injury (SCI). In “ONWARD to Recovery,” U2FP CureCast

Join the Swiss Health Valley 🇨🇭 community for the BioAlps Networking Day 2024 on 21 November in Fribourg.🤩 One week left to take advantage of our early bird fee! bioalps.org/bioalps-networ…

BioAlps' institutional member CSEM announced Andrea Dunbar as new Chief Technology Officer. 👏 She will take on her new position next January and succeed Harry Heinzelmann, who will retire after an esteemed 27-year career at CSEM. bioalps.org/csem-announces…

Vandria secures $30.7 Million in Series A funding to advance groundbreaking mitophagy therapies. The company announced the second closing of its Series A financing, bringing the final amount raised to date to $30.7 Million (CHF 28.3 Million). bioalps.org/vandria-secure…

L'écosystème d'innovation vaudois. Etat de Vaud Innovaud EPFL Innovation Park Biopôle Lausanne Trust Valley Agropôle Switzerland unlimitrust BioAlps - Life Sciences Cluster 🇨🇭 Alp ICT digitalswitzerland

🚨 Life sciences account for 10% of the Etat de Fribourg 🇨🇭 economy. Result of a BAK Economics AG study. #lifesciences generated added value of over CHF 1.5 billion in 2023 and employed 3'300 full-time equivalents #medtech #biotech #pharma bioalps.org/fribourg-econo…

Together with the Center of PhenoGenomics we are happy to announce the new Stem Cell and Organoid Lab (SCOL), now open for all EPFL research groups. P1 & P2 labs support cutting-edge organoid & iPSC research. Info 👉actu.epfl.ch/news/opening-o… Karthaus_Lab EPFL EPFL School of Engineering

🌇 A new building for Debiopharm in Lausanne! The foundation stone of this 3'500 m2 space has been laid this week. In 2026, it will house up to 300 employees. ➡️ bioalps.org/debiopharm-lay…

🚨 Congratulations HAYA Therapeutics🇨🇭 for your $1 billion collaboration with Eli Lilly and Company 🇺🇸! A great news for the Swiss Health Valley! #precisionmedicine #healthtech #RNA bioalps.org/haya-therapeut…